Potential serious adverse interactions between linezolid and atomoxetine.
Arpit
A
Aggarwal
Gaurav
G
Kulkarni
Sultana
S
Jahan
D000081:Acetamides / Q000009:adverse effects* / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology; D002648:Child; D003550:Cystic Fibrosis / Q000150:complications; D004347:Drug Interactions; D005260:Female; D006801:Humans; D000069349:Linezolid; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D023303:Oxazolidinones / Q000009:adverse effects* / Q000627:therapeutic use; D011437:Propylamines / Q000009:adverse effects* / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology
D000081:Acetamides; D000900:Anti-Bacterial Agents; D008996:Monoamine Oxidase Inhibitors; D023303:Oxazolidinones; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride; D000069349:Linezolid